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Multiple signal transduction pathways are generally triggered simultaneously by a single extracellular stimulus. As a result, multiple
transcription factors (TFs) can be activated downstream to mediate the inducible expression of target genes. Profiling the activation of all TFs
will aid in the dissection of the numerous pathways of signal transduction. Tumor necrosis factor alpha (TNFa) and phorbol 12-myristate 13-
acetate (PMA) mediate many biological functions, including cell proliferation and apoptosis, by stimulating signaling pathways. Two TFs,
nuclear factor kappaB (NFnB) and activating factor 1 (AP1), have been identified as targets of both TNFa and PMA activation. Here, we
describe the use of a protein/DNA array system to identify additional TFs activated by TNFa and PMA in HeLa cells. From a total of 150
targeted TFs, six—CREB, E2F, CETP/CRE, c-Rel, MSP1, and Pax6—were identified whose activities, like NFnB and AP1, were regulated by
both TNFa- and PMA-induced pathways. Interestingly, the TF E47 was shown to be specifically activated by TNFa but was not affected by
treatment with PMA. In addition, GATA, NF-E1, and ISRE were shown to be specifically activated by PMA but not TNFa. These findings
suggest that TNFa and PMA both stimulate unique signaling pathways while mediating transcriptional activation through common pathways.
D 2003 Elsevier B.V. All rights reserved.Keywords: Protein/DNA interaction; TNF; PMA; Transcription factor; Signal transduction1. Introduction
Signal transduction consists of biochemical events trig-
gered by extracellular stimuli that mediate intracellular
activity. The biochemical events involved in signal trans-
duction include protein–protein interactions, protein inter-
actions with a secondary messenger such as cyclic-AMP,
protein modifications, protein degradation, and protein
translocation. Combinations of these events can lead to
downstream activation of transcription factors (TFs). Acti-
vated TFs regulate the expression of target genes by
modulating the frequency of transcriptional initiation
through interaction with specific DNA-binding elements0167-4889/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0167-4889(03)00080-6
Abbreviations: TNFa, tumor necrosis factor alpha; PMA, phorbol 12-
myristate 13-acetate; CETP/CRE, cholesteryl ester transfer protein; c-Rel,
NFnB p75kDa protein; E47, E2A immunoglobulin enhancer binding
factors E12/E47; MSP1, amyloid precursor protein (APP) regulatory
element; DAG, diacylglycerol; MEKK, MAP kinase kinase kinase; NIK,
NF-{kappa}B-inducing kinase
* Corresponding author. Tel.: +1-650-216-9736; fax: 1-650-216-9790.
E-mail address: xjiang@panomics.com (X. Jiang).present in promoters. Differing initial extracellular stimuli
may stimulate distinct intracellular sequences of events,
known as signaling pathways, and consequently lead to
the eventual activation of different TFs. While signaling
pathways can operate independently of one another, there
may be overlap at one or more cellular events between
pathways, a circumstance that can result in the same TF
being activated by multiple stimuli.
TF-activating signaling pathways can be initiated by a
multitude of extracellular stimuli. Tumor necrosis factor
alpha (TNFa), for example, is a cytokine that has been
shown to be involved in many significant cellular process-
es, such as apoptosis, cell proliferation, immune response,
and inflammation. TNFa is believed to trigger signaling
pathways that ultimately lead to the activation of both
nuclear factor kappaB (NFnB) and activating factor 1
(AP1). Two of these TNFa-induced pathways have been
studied extensively; one involves the protein IKK and the
other JNK. When the IKK pathway is triggered by TNFa,
a cascade of kinases causes the activation of IKK protein,
resulting in the phosphorylation and degradation of InB, a
protein that forms a complex with NFnB and inhibits its
X. Jiang et al. / Biochimica et Biophysica Acta 1642 (2003) 1–82activity. Consequently, active NFnB is released and trans-
locates from the cytoplasm to the nucleus [1]. Binding of
TNFa to its receptor is also reported to activate the PKC/
JNK pathway, which, in turn, leads to the activation of
AP1 [2,3].
Signaling pathways are also triggered by cellular expo-
sure to phorbol esters, which have been implicated in a
variety of biological processes. Like TNFa, phorbol 12-
myristate 13-acetate (PMA), in particular, has been shown
to induce the activation of both NFnB and AP1 [4,5]. PMA
and other related phorbol esters activate members of the
PKC family by binding a cysteine-rich region that is
physiologically recognized by DAG, which leads to the
activation of the MAPK pathway [6,7]. JNK, a member of a
MAPK subgroup, binds to the AP-1 component, c-Jun, and
phosphorylates its N-terminal activation domain, thereby
increasing the transcriptional activity of c-Jun. c-Jun can
also homo- or heterodimerize with other leucine zipper
proteins to form AP-1 complexes. Additionally, JNK phos-
phorylates JunD, another potential component of AP-1. All
of these proteins have an activating effect on AP1. Activated
PKC protein was also reported to activate the InB kinase,
IKK, through a mechanism similar to that of TNFa, and
activates NFnB [8].
Through signaling pathways involving JNK and IKK,
two distinct stimuli (TNFa and PMA) are involved in the
activation of the same two TFs, NFnB and AP1. To
investigate other signaling pathways that TNFa and PMA
might affect, we sought to profile the other TFs activated by
treatment of HeLa cells with TNFa and PMA. Convention-
ally, the activity of TFs has been analyzed in vitro by gel
shift assays, otherwise known as electrophoretic mobility
shift assays (EMSA), or in vivo with reporter assays. In a
gel shift assay, a DNA cis-element is pre-labeled and then
mixed with the sample to be analyzed. When a TF is
activated, it binds to the cis-element and causes a mobility
shift during electrophoresis. The more slowly migrating
protein-bound DNA can then be visualized. With a reporter
gene assay, a specific cis-element is genetically linked to a
minimal promoter and a reporter gene. When the TF is
activated and binds to the cis-element, it activates the
transcription of the reporter gene. The activated reporter
can then be easily analyzed, e.g. by an enzyme assay. Both
in vitro and in vivo assays, however, can detect activation of
only one TF per reaction and, therefore, are not suited to
analyzing multiple TFs simultaneously.
We have recently developed a novel array technology
that makes possible high-throughput functional analysis of
TFs. With this simple array-based assay, the activities of
multiple TFs can be elucidated in a single experiment. In the
present study, the protein/DNA array system is used to
determine which TFs among the 150 that are included in
the two versions of the protein/DNA array are activated by
treatment with TNFa or PMA. To confirm the reliability of
this array technology, the activation of TFs was confirmed
by conventional gel shift assay.2. Materials methods
2.1. Nuclear extraction
HeLa cells were cultured in 100-cm culture plates in
Dulbecco’s Minimal Essential Eagle’s medium (Invitrogen)
supplemented with 10% FBS, 1% nonessential minimal
amino acids and 100 U/ml penicillin, 0.1 mg/ml streptomy-
cin. Cells (about 80% confluent) were treated with 20 ng/ml
TNFa or 10 ng/ml PMA plus ionophore (1 AM) for 30 min.
Untreated cells were used as negative controls. Nuclear
extracts from cells were prepared with nuclear extract kit
(Panomics, Inc., Redwood City, CA) according to the user
manual. Cells were washed twice in phosphate-buffered
saline (PBS), lysed on ice for 10 min in extraction buffer
A (10 mM HEPES; pH7.9, 10 mM KCl; 10 mM EDTA,
protease inhibitor cocktail (Sigma) and 4% IGEPAL) with
gently shaking. Cells were harvested from the culture dishes
by scraping into the extraction buffer and then pipetting up
and down several times to disrupt cell clumps. Nuclei were
collected by centrifugation 15000 g for 3 min. The result-
ing pellet was then resuspended in 200 Al of extraction buffer
B (20 mM HEPES, pH7.9; 400 mM NaCl; 1 mM EDTA;
10% glycerol; protease inhibitor; 10 mM DTT) and mixed at
4 jC for 2 h. The mixture was then centrifuged for 5 min at
15,000 g and the supernatant collected. Protein concen-
trations were determined by the Bradford assay (Bio-Rad).
2.2. Array analysis
Each array assay performed in this study was carried out
following the procedure in the TranSignal Protein/DNA
array kit user manual (Panomics) and the additional infor-
mation can be found in Panomics’ website. We selected 150
DNA-binding elements that correspond to well-studied TFs
via literatures, which are now listed in Panomics’ website
www.panomics.com). According to the sequences of the
DNA binding elements, we synthesized the double-stranded
oligonucleotide probes. One of the double strands is bio-
tinated. The double-strand probes were mixed to make two
libraries, one containing 54 DNA-binding elements in array
I and another 96 in array II. The unlabeled single strands
were spotted onto a nylon-based membrane. All DNA-
binding elements were spotted in duplicate on both array I
and array II and also 10-fold dilutions of these elements on
array I. Biotinylated ubiquitin was also spotted on the
membrane in the last column and bottom row as a reference
for proper exposure times. Twenty-microgram nuclear ex-
tract (5 Ag/Al) was mixed with probe mix and the mixture
was incubated at 15 jC for 30 min. The entire content of the
mixture was loaded on a 2% agarose gel and electrophor-
esed at 120 V in 0.5% TBE for 20 min. The gel area from
above the blue dye to the loading well, which represents the
migration distance of any protein/DNA complexes, was
excised from the agarose gel. The DNA probes were
recovered from the protein/DNA complexes and denatured
at
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Table 1
Schematic diagram of the TranSignal protein/DNA Array I
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
A AP1(1) AP1 AP-2 AP-2 AR AR Brn-3 Brn-3 C/EBP C/EBP CBF CBF CDP CDP c-Myb c-Myb AP1(2) AP1(2)
B AP1(1) AP1 AP-2 AP-2 AR AR Brn-3 Brn-3 C/EBP C/EBP CBF CBF CDP CDP c-Myb c-Myb AP1(2) AP1(2)
C CREB CREB E2F-2 E2F-2 EGR EGR ER ER Ets Ets Ets-1/PEA3 Ets-1/PEA3 FAST-1 FAST-1 GAS/ISRE GAS/ISRE AP-2(2) AP-2(2)
D CREB CREB E2F-2 E2F-2 EGR EGR ER ER Ets Ets Ets-1/PEA3 Ets-1/PEA3 FAST-1 FAST-1 GAS/ISRE GAS/ISRE AP-2(2) AP-2(2)
E GATA GATA GR GR HNF-4 HNF-4 IRF-1 IRF-1 MEF-1 MEF-1 MEF-2 MEF-2 Myc-Max Myc-Max NF-1 NF-1
F GATA GATA GR GR HNF-4 HNF-4 IRF-1 IRF-1 MEF-1 MEF-1 MEF-2 MEF-2 Myc-Max Myc-Max NF-1 NF-1
G NFATc NFATc NF-E1
(YY1)
NF-E1
(YY1)
NF-E2 NF-E2 NFkB NFkB Oct-1 Oct-1 p53 p53 Pax-5 Pax-5 Pbx1 Pbx1
H NFATc NFATc NF-E1
(YY1)
NF-E1
(YY1)
NF-E2 NF-E2 NFkB NFkB Oct-1 Oct-1 p53 p53 Pax-5 Pax-5 Pbx1 Pbx1
I Pit 1 Pit 1 PPAR PPAR PR PR RAR RAR RXR RXR SIF SIF Smad Smad Smad3/4 Smad3/4
J Pit 1 Pit 1 PPAR PPAR PR PR RAR RAR RXR RXR SIF SIF Smad Smad Smad3/4 Smad3/4
K Sp1 Sp1 SRF SRF Stat1 Stat1 Stat3 Stat3 Stat4 Stat4 Stat5 Stat5 Stat6 Stat6 TFIID TFIID
L Sp1 Sp1 SRF SRF Stat1 Stat1 Stat3 Stat3 Stat4 Stat4 Stat5 Stat5 Stat6 Stat6 TFIID TFIID
M TR(1) TR(1) TR(2) TR(2) USF-1 USF-1 VDR VDR HSF HSF MRF MRF
N TR(1) TR(1) TR(2) TR(2) USF-1 USF-1 VDR VDR HSF HSF MRF MRF
The response elements on the array are spotted in duplicate: the first row is DNA spotted normally, the second row is DNA diluted 1:10. The right and bottom sides of the array indicate where biotinylated DNA has
been spotted. Most of TFs are named as standard nomenclature that can be found from literatures. For those TFs that do not have a standard nomenclature, they are explained here. SIF, serum inducible factor.
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X. Jiang et al. / Biochimica et Biophysica Acta 1642 (2003) 1–84TCC GCG GCC ATC TTG GCG GCT GGT; CETP-CRE
GGCAAAAATGGTGCAGATGGTGGAGGGG; c-Rel:
GGGGAT TTC CGGGGATTT CCGGGGATT TCC; E47:
CCG GCA GGT GTC CCC CCG GCA GGT GTC CCC;
MSP1: AAG CCG GGT ATA TGG GAT CAG CTG ACT
CTC CCGGCT; MUSF1: AAG CCGGGT GGG CGGGAT
GTT AGA ACT CTC CCG GCT; ISRE: CAG TTT CAC
TTTCCCCAGTTTCACTTTCCC; Pax3: GATCCTGAG
TCTAATTGGATCCTGAGTCTAATTG; and Pax6: ATC
CAG GTC TAC TAC ATT AGT TCC AGG TCA G. The
reactions were incubated at 15 jC for 30 min. The negative
control consisted of free probe only, nuclear extracts being
replaced with water. A competition control was set up by
adding non-biotin-labeled cold probes to the reaction. The
samples were electrophoresed on a 6% polyacrylamide gel in
0.5% TBE for 45 min at 120 V. The samples were then
transferred in 0.5% TBE onto a nylon membrane at 300 mA
for 40 min. After transfer, the sample was fixed on the mem-
brane by UV cross-linking.
2.4. Detection
For both EMSA and array analyses, the membrane was
first blocked with 1% blocking reagent (Roche Molecular
Biochemicals) at room temperature for 30 min. The biotin-
labeled probe was then detected with Streptavidin–HRP
diluted 1:20000 (Pierce). After washing three times and
equilibrating in buffer, the membrane was overlaid with
lumino/enhancer and substrate for 5 min. The image was
acquired using a FluorChem imager (Alpha Innotech Corp.).
3. Results and discussion
To examine how many TFs were activated by TNFa,
HeLa cells were treated with TNFa prior to preparation of
nuclear extracts for analysis with the Protein/DNA arrayFig. 2. Array I analysis of HeLa and TNFa-treated HeLa cells. The array procedu
(B) TNFa-treated HeLa cells. The induction of NKnB was confirmed by EMSA (
lane 3, TNFa-treated HeLa nuclear extract; lane 4, TNFa-treated HeLa extract w(Fig. 1). The nuclear extracts were mixed with a biotin-
labeled pool of DNA probes that correspond specifically to
TF response elements selected from published sequences.
After the individual probes were allowed to bind with
specific TFs, the protein/DNA complexes were separated
from the free probes by agarose gel electrophoresis before
extraction and purification from the gel. The composition
and quantity of the extracted probes was then determined
using the protein/DNA array membrane, which contains the
pre-spotted unlabeled elements that will hybridize with any
labeled probes that are present. The hybridized spots were
detected with Streptavidin–HRP and HRP substrate. The
resulting images were acquired by FluorChem imager and
quantitatively analyzed with built-in software.
When TNFa-treated and untreated HeLa cells were
compared by the Protein/DNA array I (see Table 1 for the
list of TFs that are included in the array), activation of
NFnB, AP1, E2F and CREB was detected (Fig. 2A and B).
TNFa-mediated activation of these four factors has been
described previously [1,3,9,10]. The quantitative analysis of
the image results indicated twofold induction. The array
results were further confirmed by gel shift assay. As shown
in Fig. 2C, TNFa activation of NFnB was confirmed by gel
shift assay. As a control, we also looked at results with
MEF1. In both the array and EMSA analyses, there is no
difference in the activity of MEF1 between the TNFa-
treated and untreated HeLa nuclear extracts (data not
shown), thus confirming that NFnB, AP1, E2F, and CREB
are indeed activated by TNFa. Both TNFa-treated and
untreated HeLa nuclear extracts were further analyzed with
protein/DNA array II (see Table 2 for the list of TFs that are
included). It should be noted that the spotting format of
array II is different from array I. Array II consists of only
two spots of immobilized DNA per cis-element whereas
Array I has four—two of which are 10 diluted. As shown
in Fig. 3A and B, multiple TFs were observed whose
activities were induced by TNFa. The activation of fivere was performed using nuclear extracts from (A) untreated HeLa cells and
C). For each TF, lane 1 represents free probe; lane 2, HeLa nuclear extract;
ith competing unlabelled probe.
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X. Jiang et al. / Biochimica et Biophysica Acta 1642 (2003) 1–8 5TFs—CETP/CRE, c-Rel, E47, MSP1, and pax6—whose
induction was over twofold, was further verified by gel shift
assay (Fig. 3C). The gel shift assay confirms the array
results. Pax3 that had not shown any observable change on
the array upon treatment with TNFa was used as a control
for the gel shift assay. The activity of Pax3, as shown by the
gel shift assay, did not change upon TNFa treatment (Fig.
3C). Based on these results, we conclude that the array
method is a sensitive and accurate method for identifying
TFs whose activities change under specific conditions.
It has been shown previously that PMA stimulates similar
signaling pathways to TNFa. Therefore, it was thought that
the newly identified TNFa-activated TFs might also be
induced by PMA treatment. To determine if PMA-induced
TFs were identical to those induced by TNFa, HeLa cells
were first treated with PMA. Nuclear extracts were prepared
from both treated and untreated cells, and were subjected to
the same array analysis as the TNFa-treated cells. As shown
in Fig. 4A and B, both AP1 and NFnB were activated by
PMA, as expected. A number of other TFs whose activation
by PMA has been demonstrated previously—CREB, E2F1,
Egr, GATA, and NF-E1 (YY1)—were also shown to be
induced more than twofold (Fig. 4A and B). The PMA
activation of these factors was confirmed by gel shift assay
(Fig. 4C shows NF-E1 and GATA). PMA-treated cells were
then applied to array II. Seven additional TFs in Fig. 5A and
B were shown to be induced by PMA. The activation of five
TFs, CETP/CRE, MSP1, ISRE, MUSF1, and Pax6, was
confirmed by gel shift assay (Fig. 5C).
Of known TFs, it is currently unclear how many can be
activated by these two stimuli. The lack of empirical work
investigating this question is mainly a result of the low-
throughput of conventional methods for the study of TF
activation, which is therefore ill suited to such extensive
research. With the new protein/DNA array technology, it
now becomes possible to address this question. Among the
factors that are included in the two versions of the array, six
TFs—CREB, E2F, CETP/CRE, c-rel, MSP1, and Pax6—
were identified in this study whose activities, like NFnB and
AP1, were increased by both TNFa and PMA treatment. In
addition, the TF E47 was shown to be specifically activated
by TNFa but not by PMA. Furthermore, the TFs GATA,
NF-E1, and ISRE were shown to be specifically activated
by PMA but not by TNFa.
Activation of NFnB and AP1 by TNFa and PMA was
well documented prior to this study. TNFa activates NFnB
through the TNFR-MEKK1-IKK pathway, and AP1 through
the TNFR-MEKK1-JNK pathway, while PMA activates
AP1 through the PKC-MEKK1-JNK pathway, and NFnB
through PKC-MEKK1-IKK [11]. As shown in the present
study, TFs c-rel, CREB, E2F, CETP/CRE, MSP1, and Pax6
that are activated by TNFa were also activated by PMA.
These TFs were likely activated through the same pathways
that lead to the activation of NFnB and AP1: TNFR-
MEKK1-IKK and JNK. In contrast, the TF E47 was
activated by TNFa but not by PMA, indicating that this
 Fig. 3. Array II analysis of HeLa and TNFa-treated HeLa cells. The array procedure was performed using nuclear extracts from (A) HeLa cells and (B) TNFa-
treated HeLa cells. The induction of CETP/CRE, c-Rel, E47, MSP1, Pax6 and Pax3 (from left to right) was confirmed by EMSA (C). For each TF, lane 1
represents free probe; lane 2, HeLa nuclear extracts; lane 3, TNFa-treated HeLa nuclear extract; lane 4, TNFa-treated HeLa nuclear extract with competing
unlabelled probe.
X. Jiang et al. / Biochimica et Biophysica Acta 1642 (2003) 1–86specific factor might be activated by IKK only. E47 is a
helix-loop-helix TF that arises from alternative splicing of
the E2A gene, and is a central regulator in B cell differen-
tiation. Previous studies reported that E47 could potentially
be activated via the Ras-ERK-MAPK cascade in thymo-
cytes [12,13]. The present study suggests that, at least in
HeLa cells, there is an additional pathway to activate E47.
In addition, a number of factors—GATA, EGR, NF-E1
(YY1), and ISRE—were shown to be activated only by
PMA and not TNFa. These TFs have all been well charac-Fig. 4. Array I analysis of HeLa and PMA-treated HeLa cells. The array procedur
treated HeLa cells. The induction of NF-E1 and GATA by PMAwere confirmed by
extract; lane 3, PMA-treated HeLa nuclear extract; lane 4, PMA-treated HeLa nuterized previously [14–16]. These factors are thought to be
activated via the JNK signaling pathway. However, IKK
likely does not play a role in the activation because these
particular TFs are not activated by TNFa treatment.
An estimated 20% of cellular proteins are TFs. Profiling
the activities and characterizing the signaling pathways of
all these factors will be a momentous task. The conventional
methods for TF study are barely capable of meeting the
challenge because of their low-throughput capability. The
Protein/DNA array technology represents a high-throughpute was performed using nuclear extracts from (A) HeLa cells and (B) PMA-
EMSA (C). For each TF, lane 1 represents free probe; lane 2, HeLa nuclear
clear extract with competing unlabelled probe.
Fig. 5. Array II analysis of HeLa and PMA-treated HeLa cells. The array procedure was performed using nuclear extracts from (A) HeLa cells and (B) PMA-
treated HeLa cells. The inductions of ISRE, MSP1, MUSF, CETP/CRE and Pax6 (from left to right) were confirmed by EMSA (C). For each TF, lane 1
represents free probe; lane 2, HeLa nuclear extracts; lane 3, PMA-treated HeLa nuclear extracts; lane 4, PMA-treated HeLa nuclear extracts with competing
unlabelled probe.
X. Jiang et al. / Biochimica et Biophysica Acta 1642 (2003) 1–8 7method for the characterization of TF activation. Because
this novel system allows multiple TFs to be profiled
simultaneously, it provides a fast and simple tool to deter-
mine the activity changes of TFs where the previous
methods had been slow and cumbersome. There are a
couple of disadvantages in the current version of the array
assay as gel separation is used for separation of the com-
plexes from the free probes and biotin for detection. Gel
separation makes it difficult to automate the array assay
procedure. Compared to fluorescent detection, biotin detec-
tion can only make the assay as a semi-quantitative assay
method. Nevertheless, study of the transcriptional activity of
normal, cancerous, proliferating, arrested, apoptotic, differ-
entiated, drug-treated, or any disease-related human cells
will be greatly facilitated by this array system, although the
disadvantages exist in the current version. Application of the
technology in the present study demonstrates the potential
of this approach for rapidly and effectively characterizing
activity changes of TFs.Acknowledgements
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